LFWD logo

Lifeward Ltd. Stock Price

NasdaqCM:LFWD Community·US$9.7m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

LFWD Share Price Performance

US$0.58
-1.77 (-75.26%)
92.7% undervalued intrinsic discount
US$8.00
Fair Value
US$0.58
-1.77 (-75.26%)
92.7% undervalued intrinsic discount
US$8.00
Fair Value
Price US$0.58
AnalystConsensusTarget US$8.00
AnalystHighTarget US$13.00
AnalystLowTarget US$1.00

LFWD Community Narratives

AnalystConsensusTarget·
Fair Value US$8 92.7% undervalued intrinsic discount

Expanding International Healthcare Access And Efficiencies Will Unlock Value

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AnalystHighTarget·
Fair Value US$13 95.5% undervalued intrinsic discount

Global Aging And Robotics Integration Will Unlock New Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystLowTarget·
Fair Value US$1 41.9% undervalued intrinsic discount

Slow Medicare Reimbursements Will Undermine Efficiency But Foster Resilience

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Snowflake Analysis

High growth potential with adequate balance sheet.

3 Risks
2 Rewards

Lifeward Ltd. Key Details

US$24.4m

Revenue

US$16.1m

Cost of Revenue

US$8.3m

Gross Profit

US$38.1m

Other Expenses

-US$29.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-1.89
34.17%
-121.80%
0%
View Full Analysis

About LFWD

Founded
2001
Employees
80
CEO
William Grant
WebsiteView website
golifeward.com

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals’ post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.

Recent LFWD News & Updates

Even With A 27% Surge, Cautious Investors Are Not Rewarding Lifeward Ltd.'s (NASDAQ:LFWD) Performance Completely

Sep 25
Even With A 27% Surge, Cautious Investors Are Not Rewarding Lifeward Ltd.'s (NASDAQ:LFWD) Performance Completely

Recent updates

No updates